GGPS1 Human

Geranylgeranyl Diphosphate Synthase 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Function and Biochemical Role

GGPS1 catalyzes the sequential condensation of isopentenyl pyrophosphate (IPP) with farnesyl pyrophosphate (FPP) to produce GGPP . This reaction is vital for:

  • Protein geranylgeranylation: Post-translational modification of small GTPases (e.g., Rho, Rac), enabling membrane localization and function in cytoskeletal regulation and signal transduction .

  • Metabolic precursors: GGPP serves as a substrate for vitamin K2, ubiquinone (coenzyme Q10), and dolichol biosynthesis .

Key Enzymatic Properties

PropertyHuman GGPS1
Gene locationChromosome 1 (1q32.1)
Protein length300 amino acids
Molecular mass~34.8 kDa
Quaternary structureHexameric assembly
InhibitorsBisphosphonates (e.g., zoledronate)

Comparative Quaternary Structures

OrganismStructureFunctional Implications
HumanHexamerEnhanced stability and regulation
E. coliDimerSimpler catalytic activity
ArchaeoglobusDimerLimited regulatory capacity

Clinical and Disease Associations

Mutations in GGPS1 are linked to rare genetic disorders and metabolic dysregulation:

Genetic Disorders

  • Muscular dystrophy with hearing loss and ovarian insufficiency: Biallelic mutations (e.g., R261H, F257C) disrupt GGPP synthesis, impairing protein prenylation and cellular homeostasis .

  • Perrault syndrome 2: A syndromic form of ovarian dysgenesis and sensorineural hearing loss .

Cancer and Metabolic Diseases

DiseaseRole of GGPS1Mechanism
Oral squamous cell carcinomaOverexpression correlates with poor prognosisAltered lipid metabolism and chemokine signaling
Hepatocellular carcinomaPromotes cholesterol accumulationDysregulated terpenoid biosynthesis
Type 2 diabetesModulates insulin resistanceImpaired geranylgeranylation of Rho GTPases

Therapeutic Targeting

  • Bisphosphonates: Inhibit GGPS1 activity, reducing GGPP-dependent protein prenylation in bone disorders and cancers .

  • Gene knockout studies: GGPS1 deficiency attenuates sepsis-induced lung injury and cancer metastasis in preclinical models .

Metabolic Pathways

GGPS1 intersects with critical pathways:

  • Terpenoid backbone biosynthesis

  • Cholesterol metabolism

  • Oxidative phosphorylation

Protein Conservation Across Species

GGPS1 is highly conserved, with homologs in mammals, insects, and plants:

SpeciesProtein LengthMolecular Mass (Da)
Human30034,871
Mouse30034,707
Rat30034,778
Source:

Future Directions

Current research focuses on:

  • Small-molecule inhibitors for cancer therapy .

  • Gene-editing approaches to correct GGPS1 mutations in congenital disorders .

  • Metabolic profiling to elucidate GGPP’s role in aging and neurodegenerative diseases .

Product Specs

Introduction
GGPS1, a member of the prenyltransferase family, is widely expressed, particularly in the testis, heart, and skeletal muscle. Primarily located in the cytoplasm, GGPS1 catalyzes the formation of geranylgeranyl pyrophosphate, a key precursor for geranylgeranylated proteins and carotenoids. This enzyme plays a crucial role in the C20-prenylation of proteins and the regulation of a nuclear hormone receptor.
Description
Recombinant Human GGPS1, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 320 amino acids, with a sequence spanning from 1 to 300 a.a., and has a molecular weight of 37 kDa. The GGPS1 protein is fused to a 20 amino acid His-Tag at its N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized through filtration.
Formulation
The GGPS1 Human recombinant protein solution is provided at a concentration of 1 mg/ml and contains 20mM Tris-HCl buffer with a pH of 8, 1mM DTT (dithiothreitol), and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended periods, it is recommended to store the solution frozen at -20°C. Adding a carrier protein like 0.1% HSA or BSA is advisable for long-term storage. To maintain protein integrity, avoid repeated cycles of freezing and thawing.
Purity
The purity of the GGPS1 protein is greater than 90.0%, as determined by SDS-PAGE analysis.
Synonyms
GGPPS, GGPPS1, GGPP synthetase.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MEKTQETVQR ILLEPYKYLL QLPGKQVRTK LSQAFNHWLK VPEDKLQIII EVTEMLHNAS LLIDDIEDNS KLRRGFPVAH SIYGIPSVIN SANYVYFLGL EKVLTLDHPD AVKLFTRQLL ELHQGQGLDI YWRDNYTCPT EEEYKAMVLQ KTGGLFGLAV
GLMQLFSDYK EDLKPLLNTL GLFFQIRDDY ANLHSKEYSE NKSFCEDLTE GKFSFPTIHA IWSRPESTQV QNILRQRTEN IDIKKYCVHY LEDVGSFEYT RNTLKELEAK AYKQIDARGG NPELVALVKH LSKMFKEENE.

Product Science Overview

Function and Mechanism

GGPS1 catalyzes the trans-addition of three molecules of isopentenyl pyrophosphate (IPP) onto dimethylallyl pyrophosphate (DMAPP) to form GGPP . GGPP is a key precursor for the C20-prenylation of proteins, which is essential for the post-translational modification of proteins, including those in the Ras superfamily of small GTPases . These modifications are critical for the proper functioning of various cellular processes, including signal transduction, cell growth, and differentiation .

Genetic and Molecular Characteristics

The GGPS1 gene is located on chromosome 1q42.3 . It encodes a protein that consists of 300 amino acids and contains five conserved domains typical of prenyltransferases . The enzyme is ubiquitously expressed in various tissues, with the highest expression observed in the heart, skeletal muscle, and testis .

Clinical Significance

Mutations or dysregulation of the GGPS1 gene have been associated with several diseases, including muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome . The enzyme’s role in the mevalonate/isoprenoid pathway also implicates it in the regulation of lipid synthesis and small GTPase activity, which are fundamental to numerous cellular functions .

Research and Applications

Recombinant human GGPS1 is widely used in research to study its function and regulation. It is also utilized in the development of therapeutic strategies targeting the isoprenoid biosynthesis pathway for the treatment of various diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.